Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze NTLA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate NTLA investment potential.

What is NTLA stock price today?

Get real-time NTLA stock price, historical data, and price charts on Financhill. Track NTLA performance with our advanced analysis tools.

Is NTLA a good investment?

Evaluate NTLA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy NTLA stock?

To buy NTLA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of NTLA?

View detailed market capitalization data and company valuation metrics for NTLA on our comprehensive analysis page.

What is the P/E ratio of NTLA?

Use our fundamental analysis tools to view NTLA P/E ratio and compare valuation metrics with industry peers.

What are NTLA earnings?

View NTLA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Intellia Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

NTLA
Intellia Therapeutics, Inc.

Last Price:

$13.12

Seasonality Move:

13.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Intellia Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Intellia Therapeutics, Inc. has on average historically risen by 40.1% based on the past 9 years of stock performance.
Intellia Therapeutics, Inc. has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Is Intellia Therapeutics, Inc. Stock Undervalued?

The current Intellia Therapeutics, Inc. [NTLA] share price is $13.13. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Intellia Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Intellia Therapeutics, Inc. has on average historically risen by 40.1% based on the past 9 years of stock performance.

Intellia Therapeutics, Inc. Stock Rating

Sell

Intellia Therapeutics, Inc. (NTLA) is a Sell

Is Intellia Therapeutics, Inc. overpriced?

Intellia Therapeutics, Inc. has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Intellia Therapeutics, Inc. Stock Price History

Is NTLA stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

intelliatx.com

52-Week Data

52-Week High:

28.25

52-Week Low:

5.90

Prediction Charts

Market Cap:

1.5B

Price in USD:

13.13

Volume:

2.7M

Beta:

2.08

Technical Analysis

SMA50:

13.15

SMA100:

11.38

SMA200:

12.79

52-Wk Change:

79.86%

Stock Predictions

Is Intellia Therapeutics, Inc. stock public?

Yes, Intellia Therapeutics, Inc. is a publicly traded company.
What is the Intellia Therapeutics, Inc. stock quote today?

The Intellia Therapeutics, Inc. stock price is 13.13 USD today.
How to buy Intellia Therapeutics, Inc. stock online?

You can buy Intellia Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-16	13.05	13.38	13.66	12.88
Mar-17	13.38	13.48	13.66	13.38
Mar-18	13.20	13.21	13.65	13.14
Mar-19	12.91	13.15	13.46	12.66
Mar-20	13.13	12.84	13.58	12.81
Mar-23	12.93	13.11	13.34	12.66
Mar-24	12.95	12.81	13.18	12.63
Mar-25	13.11	13.26	13.67	13.03
Mar-26	13.02	13.24	14.02	12.82
Mar-27	13.12	12.37	13.16	12.12
Mar-30	12.36	11.65	12.36	11.62
Mar-31	11.87	12.82	12.99	11.87
Apr-1	12.95	13.27	13.65	12.95
Apr-2	12.69	13.13	13.27	12.47

Intellia Therapeutics, Inc. Earnings

Intellia Therapeutics, Inc. Earnings Report: Per Share Intellia Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intellia Therapeutics, Inc. Forecast Revenue Growth

Intellia Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.44 per share, and an increase next year of $0.63 per share.

* Intellia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.